Abstract
Fertility preservation is a growing field in reproductive medicine that may raise
ethical questions. Preservation of fertility must be discussed with the patient if
gonadotoxic treatment is required, whether in the case of benign or malignant
pathology, or in the management of transgender identity. As a result, surgery or
chemotherapy that has fewer adverse impacts on fertility should be proposed if
this does not alter the prognosis of the disease. If the risk of infertility persists,
then fertility cryopreservation should be proposed for children and adults of reproductive
age. Sperm, oocytes, and gonadal tissue can be cryopreserved for many
years. FIGO wishes to emphasize the importance of fertility preservation in the
medical and surgical management of patients, and the importance of a specialized,
multidisciplinary approach.